Valuation: Anupam Rasayan India Ltd

Market Cap 14TCr 147.73Cr 129.75Cr 120.67Cr 110.73Cr 208.05Cr 211.25Cr 1.43TCr 559.81Cr 6.99TCr 554.58Cr 542.62Cr 24TCr P/E 2026
81.6x
P/E 2027 * 42.2x
Enterprise Value 15TCr 153.09Cr 134.46Cr 125.04Cr 114.74Cr 215.59Cr 218.91Cr 1.48TCr 580.11Cr 7.25TCr 574.69Cr 562.3Cr 25TCr EV / Sales 2026
6.55x
EV / Sales 2027 * 4.31x
Free-Float
16.12%
Yield 2026
0.12%
Yield 2027 * 0.16%
15/07 Anupam Rasayan India Limited Signs Letter Of Intent With BASQUEVOLT, S.A. For Potential Long-Term Supply Of Specialty Chemical Product Worth USD 300 Million CI
06/07 Tanfac Industries Limited announced that it expects to receive INR 1.734872962 billion in funding from Anupam Rasayan India Ltd, Alrox Enterprises Private Limited CI
11/06 Anupam Rasayan India Limited Commercialises ETFA Using Flow Chemistry CI
04/06 Crisil Places Anupam Rasayan Ratings on Watch Developing After Bliss GVS Acquisition Announcement MT
25/05 Anupam Rasayan India Ltd, Q4 2026 Earnings Call, May 25, 2026
23/05 Anupam Rasayan India Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
23/05 Anupam Rasayan India Limited Announces Resignation of Vishal Thakkar as Deputy Chief Financial Officer and Key Managerial Personnel, Effective May 23, 2026 CI
23/05 Anupam Rasayan India Ltd Recommends Final Dividend for the Financial Year 2025-26 CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd proposed to acquire 26.21% stake in Bliss GVS Pharma Limited for INR 8.3 billion. CI
23/05 Anupam Rasayan India Ltd entered into a share purchase agreement to acquire 43.30% stake in Bliss GVS Pharma Limited for INR 13.7 billion. CI
27/02 Anupam Rasayan India Ltd completed the acquisition of Jayhawk Fine Chemicals Corporation from CABB Group GmbH. CI
16/02 Anupam Rasayan India's Consolidated Profit Rises in Fiscal Q3 MT
1 day+0.91%
1 week-1.52%
Current month-1.12%
1 month-2.48%
3 months-6.97%
6 months+2.28%
Current year-5.36%
1 week 1,215
Extreme 1215
1,273.95
1 month 1,215
Extreme 1215
1,299.6
Current year 1,162.8
Extreme 1162.8
1,415.4
1 year 1,047.4
Extreme 1047.4
1,415.4
3 years 600.95
Extreme 600.95
1,415.4
5 years 547.1
Extreme 547.1
1,415.4
10 years 472.25
Extreme 472.25
1,415.4
Manager TitleAgeSince
Chief Executive Officer - 11/09/2023
Director of Finance/CFO 36 15/03/2022
Chief Operating Officer 54 23/02/2021
Director TitleAgeSince
Director/Board Member 65 25/09/2025
Chairman 50 23/04/2013
Director/Board Member 52 01/01/1992
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-1.52% - - 145.67Cr
+2.13%-1.50%-0.40%+41.87% 7.41TCr
+0.60%-6.60%-11.57%+11.24% 3.59TCr
+1.20%-1.61%-24.49%-39.45% 3.02TCr
-0.87%-0.19%+12.54%+32.87% 2.65TCr
+0.57%+3.82%+19.91%+10.81% 2.25TCr
-0.85%-1.55%+65.97%-4.82% 1.98TCr
+0.22%+1.78%-38.64%-39.20% 1.86TCr
-1.76%-4.91%+36.43%-45.52% 1.38TCr
+0.12%+3.10%+6.34%+61.50% 1.34TCr
Average +0.23%-0.67%+7.34%+3.26% 2.83TCr
Weighted average by Cap. +0.67%-1.20%+3.03%+11.00%

Financials

2026 2027 *
Net sales 2.22TCr 23Cr 20Cr 19Cr 17Cr 33Cr 33Cr 223.99Cr 88Cr 1.09TCr 87Cr 85Cr 3.78TCr 3.72TCr 39Cr 34Cr 32Cr 29Cr 54Cr 55Cr 374.99Cr 146.51Cr 1.83TCr 145.14Cr 142.01Cr 6.33TCr
Net income 158.9Cr 1.65Cr 1.45Cr 1.35Cr 1.24Cr 2.32Cr 2.36Cr 16Cr 6.25Cr 78Cr 6.19Cr 6.06Cr 270.1Cr 336.9Cr 3.5Cr 3.07Cr 2.86Cr 2.62Cr 4.93Cr 5Cr 34Cr 13Cr 165.63Cr 13Cr 13Cr 572.67Cr
Net Debt 515.9Cr 5.36Cr 4.71Cr 4.38Cr 4.02Cr 7.54Cr 7.66Cr 52Cr 20Cr 253.63Cr 20Cr 20Cr 876.94Cr 1.82TCr 19Cr 17Cr 15Cr 14Cr 27Cr 27Cr 183.37Cr 72Cr 895.07Cr 71Cr 69Cr 3.09TCr
Logo Anupam Rasayan India Ltd
Anupam Rasayan India Ltd. is an India-based company, which is engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals. The Company's segments include Life Science related Specialty Chemicals and Other Specialty Chemicals. The Life Science related Specialty Chemicals segment includes agrochemicals (including crop protection), personal care, and pharmaceuticals businesses. Its agrochemicals business includes manufacturing agro intermediates and active ingredients, such as insecticides, fungicides, herbicides and plant growth regulators. Its personal care business manufactures antibacterial and ultraviolet protection intermediates. Its pharmaceuticals business develops intermediates and key starting materials for active pharmaceutical ingredients used in therapeutic segments, including cardiovascular and antidiabetic. The Other Specialty Chemicals segment includes specialty pigments, specialty dyes, and polymer additives. It caters to Indian and global customers.
Employees
2,606
Date Price Change Volume
24/26/24 ₹1,249.20 +0.91% 7,730
23/26/23 ₹1,237.90 -0.92% 2,009
22/26/22 ₹1,249.35 -1.39% 2,228
21/26/21 ₹1,267.00 -0.10% 1,367
20/26/20 ₹1,268.25 -0.02% 2,970
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
1,249.60INR
Average target price
1,143.00INR
Spread / Average Target
-8.53%

Quarterly revenue - Rate of surprise